Shareholders of the retail pharmacy giant voted in favor of the terms of the sale to Sycamore Partners for $11.45 a share. The deal is expected to close later this year. 

After issuing a 50% tariff on copper imports this week, President Donald Trump said a massive levy on drugs could be announced “very soon.” The details are currently unknown. 

In the past year, there has been a record number of new medical AI submissions, resulting in 300 new clinical AI clearances. The number of submissions has been steadily rising over the past decade.

American Medical Association (AMA) Board of Trustees Member Scott Ferguson, MD, explains the concern that a large number of rural hospitals will close under the massive Medicaid cuts in the "Big, Beautiful Bill" passed by Congress in July 2025.  

The Pennsylvania-based health system reported drug diversion incidents to authorities involving a pharmacy technician who used employee passwords to steal pills from one of its hospitals.

Xealth’s data sharing platform will be used to make use of health information gathered from everyday devices like the Samsung Galaxy Smartwatch, the companies said.

Ballard Closed Suction Systems will need to be returned to the manufacturer for a refund due to the high risk of a potentially fatal infection stemming from their use.

The pharmacy chain said it plans to appeal the ruling. The complaint was brought by a former employee turned whistleblower who alleged that Omnicare had billed the government for millions of unnecessary prescriptions.

An exclusive interview with Hal Andrews, President and CEO of Trilliant Health, on the topic of price transparency and how regulators and companies can contain costs for patients. 

One of the picks for the Advisory Committee on Immunization Practices, Robert Malone, MD, is known for his outspoken criticism of mRNA vaccines, particularly for COVID-19. Malone believes the technology is unsafe and has been accused by public health officials of spreading medical misinformation. 

The influential task force dictates whether health insurers must cover preventive services such as mammograms and low-dose CT lung exams, which some say could be in jeopardy. 

This proposal, if finalized, would dramatically increase patient access to renal denervation. Both Recor Medical and Medtronic have shared their excitement over the news.